None listed
Conditions
Brief summary
Commercial tobacco use among Aboriginal and Torres Strait Islander people is intrinsically linked with colonisation, dispossession, and racism. Today, 43% of Aboriginal people are daily smokers and tobacco remained the largest single risk behaviour for the adverse health conditions of Aboriginal and Torres Strait Islander people, contributing 17% of total burden. Research has consistently shown that Aboriginal and Torres Strait Islander people want to quit smoking. This study is built upon a pilot trial conducted in 2022/23 (ACTRN12622000654752). This study is built upon a pilot trial conducted in 2022/23. The pilot trial showed the acceptability and feasibility of the mailout smoking cessation intervention for Aboriginal and Torres Strait Islander people. This study will provide flexible, and potentially low-cost access to evidence-based smoking cessation support for Aboriginal and Torres Strait Islander people. This study will evaluate the effectiveness of the mailout smoking cessation program using a self-reported 7-day point-prevalence and continuous abstinence at 3 months and 6 months follow-up.
Interventions
Intervention. The intervention will be 3 months in duration and includes three components: (1) Provision of a Quit Pack: participants will be mailed a Quit Pack. The Quit Pack includes readily available universal quitting resources from sources such as Quit Victoria. The Quit Pack includes pamphlets and resources on quitting, an information card on existing government-provided support options (e.g., MyQuitBuddy App, iCanQuit App, link to Aboriginal Quitline webpage), as well as health promotion and Aboriginal merchandise (e.g., a hat, socks or beanie from Clothing the Gaps, a Victorian Aboriginal led and controlled, and majority Aboriginal owned, social enterprise). Participants will be asked whether they have received the posted package and adherence to the resources will be evaluated at each follow-up. (2) Multiple offers of Nicotine Replacement Therapy (NRT): participants will be offered a 12-week course of combination NRT consistent with RACGP recommendations at baseline during the initial phone call post enrolment. Intervention check-ins will take place at 2, 6, and 10 weeks for all participants to allow for re-assessment of required strength and preferences regarding formulations of NRT. Available NRT will include 21mg nicotine patches and faster-acting oral NRT formulations (lozenge, gum, inhalator) as combination NRT, consistent with RACGP smoking cessation guidelines. Participants who want to use NRT will have it mailed to their homes after each check-in time point. (3) Multiple offers of behavioural counseling. A Research Assistant will explain that the most effective way to quit smoking is to combine a combination of NRT with support to manage cravings and triggers to smoke, which is provided by Aboriginal Quitline. All participants will be offered a call from Aboriginal Quitline (proactive referral) at each follow-up contact starting from the initial phone call post enrolment and Quitline will call those who consent. Quitline will encourage and monitor the use of supplied NRT, explore any barriers to use, and will check for correct techniques to help maximise the effectiveness of the supplied products. Quitline will also provide written and other resources as required and can link participants up with local support groups if requested.
Sponsors
Study design
Eligibility
Inclusion criteria
To be eligible to participate, individuals will need to self-identify as an Aboriginal or Torres Strait Islander current daily smoker aged 16 years and above, who resides in a participating state or territory (NSW, Victoria, and the ACT), and plans to quit smoking in the 30 days following enrolment to the program.
Exclusion criteria
Non-Aboriginal people, Non-smokers, Age less than 16 years old, Aboriginal and Torres Strait Islander people who live outside of NSW, ACT or Victoria